| 2024 | Comparison of Adverse Events Between PARP Inhibitors in Patients with Epithelial Ovarian Cancer: A Nationwide Propensity Score Matched Cohort Study | TARGETED ONCOLOGY |
| 2023 | Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer
| BRITISH JOURNAL OF CANCER |
| 2023 | TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway
| NATURE COMMUNICATIONS |
| 2023 | Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment
| CANCERS |
| 2023 | High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer
| ONCOLOGY REPORTS |
| 2023 | Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer
| FRONTIERS IN ONCOLOGY |
| 2023 | High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2022 | High FKBPL expression contributes to cell proliferation by regulating the cell cycle and affects prognosis in ovarian cancer patients | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | HIGH EXPRESSION OF VACUOLAR-ATPASE SUBUNIT ATP6V1B1 PROMOTES POOR PROGNOSIS AND TUMORIGENIC CHARACTERISTICS IN EPITHELIAL OVARIAN CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | HIGH EXPRESSION OF TRAFFICKING PROTEIN TRANSMEMBRANE P24 TRAFFICKING PROTEIN9 PROMOTES POOR PROGNOSIS OF EPITHELIAL OVARIAN CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | HIGH EXPRESSION OF PHOSPHODIESTERASE 1 (PDE1A) PROMOTES POOR PROGNOSIS AND ASSOCIATED WITH PLATINUM BASED CHEMOTHERAPY RESISTANCE IN EPITHELIAL OVARIAN CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis
| CANCER GENOMICS & PROTEOMICS |
| 2022 | RNA sequencing and bioinformatics analysis revealed PACSIN3 as a potential novel biomarker for platinum resistance in epithelial ovarian cancer | JOURNAL OF GENE MEDICINE |
| 2022 | NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells
| JOURNAL OF CELLULAR AND MOLECULAR MEDICINE |
| 2022 | Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2022 | NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59
| SCIENTIFIC REPORTS |
| 2022 | Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models
| CANCERS |
| 2021 | CRY1 Regulates Chemoresistance in Association With NANOG by Inhibiting Apoptosis via STAT3 Pathway in Patients With Cervical Cancer
| CANCER GENOMICS & PROTEOMICS |
| 2021 | LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells
| AUTOPHAGY |
| 2021 | Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
| EXPERIMENTAL AND THERAPEUTIC MEDICINE |
| 2021 | Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial Ovarian Cancer
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2021 | The Combination of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) is an Effective Prognostic Biomarker in Cervical Cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY |
| 2021 | MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors
| PLOS PATHOGENS |
| 2020 | TOM40 Inhibits Ovarian Cancer Cell Growth by Modulating Mitochondrial Function Including Intracellular ATP and ROS Levels
| CANCERS |
| 2020 | Prognostic Significance of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) in Epithelial Ovarian Cancer
| CANCER GENOMICS & PROTEOMICS |
| 2020 | CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer | GYNECOLOGIC ONCOLOGY |
| 2020 | HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors
| NATURE COMMUNICATIONS |
| 2019 | Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer
| BMC CANCER |
| 2019 | Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer | Cancer genomics & Proteomics |
| 2019 | Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer | INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY |
| 2019 | ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer
| CANCERS |
| 2019 | Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth | INTERNATIONAL JOURNAL OF HYPERTHERMIA |
| 2018 | Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
| Obstetrics & Gynecology Science |
| 2018 | Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression
| PLOS ONE |
| 2018 | Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance
| JOURNAL OF CLINICAL INVESTIGATION |
| 2018 | Histomorphological and Molecular Assessments of the Fixation Times Comparing Formalin and Ethanol-Based Fixatives. | JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY |
| 2018 | DNA mismatch repair protein immunohistochemistry and MLH1 promotor methylation testing for practical molecular classification and the prediction of prognosis in endometrial cancer
| CANCERS |
| 2018 | Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF | CELL DEATH AND DIFFERENTIATION |
| 2018 | Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis | CANCER RESEARCH |
| 2018 | Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer | GYNECOLOGIC ONCOLOGY |
| 2018 | Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models
| CANCER RESEARCH AND TREATMENT |
| 2017 | API5 induces cisplatin resistance through FGFR signaling in human cancer cells
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2017 | HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells | CANCER RESEARCH |
| 2017 | Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer | ANTICANCER RESEARCH |
| 2017 | Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2017 | REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival
| CELL DEATH & DISEASE |
| 2016 | Over-expression of BMI1 is associated with favorable prognosis in cervical cancer
| INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY |
| 2016 | A melanin-bleaching methodology for molecular and histopathological analysis of formalin-fixed paraffin-embedded | LABORATORY INVESTIGATION |
| 2016 | Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology
| MEDICINE |
| 2016 | The paraffin-embedded RNA metric (PERM) for RNA isolated from formalin-fixed, paraffin-embedded tissue
| BIOTECHNIQUES |
http://orcid.org/0000-0002-6177-1648
(25821674300)
